Download PDF
Synthesis 2008(15): 2398-2404  
DOI: 10.1055/s-2008-1067129
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

An Efficient Synthesis of ABT-263, a Novel Inhibitor of Antiapoptotic Bcl-2 Proteins

Guangjun Wanga,b,c, Hushan Zhangb, Jing Zhoub, Chengyong Haa, Duanqing Peib, Ke Ding*b
a Key Laboratory of Cellulose and Lignocellulosics Chemistry, Guangzhou Institute of Chemistry, Chinese Academy of Sciences, Guang­zhou 510650, Guangdong, P. R. of China
b Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, International Business Incubator A-3, Guangzhou Science Park, Guangzhou 510663, Guangdong, P. R. of China
Fax: +86(20)32290485; e-Mail: ding_ke@gibh.ac.cn;
c Graduate School of the Chinese Academy of Sciences, Beijing 100039, Beijing, P. R. of China
Further Information

Publication History

Received 27 February 2008
Publication Date:
11 June 2008 (online)

    Permissions and Reprints All articles of this category

Abstract

ABT-263, a newly developed Bcl-2 inhibitor, was efficiently synthesized. The key intermediates 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enyl]methyl}piperazin-1-yl)benzoic acid and 4-fluoro-3-[(trifluoromethyl)sulfonyl]benzenesulfon­amide were efficiently prepared by a three-component Mannich reaction­ and by nucleophilic fluorination of 1-nitro-2-[(trifluoro­methyl)sulfonyl]benzene as the key steps, respectively. Our work may lay a foundation for a new process development of this promising anticancer drug candidate.

Key words

Bcl-2 family protein inhibitor - anticancer drugs - ABT-263­ - synthesis - sulfonamides

    References

  • 1 Adams JM. Cory S. Science  1998,  281:  1322 
    CrossrefPubMedGoogle Scholar
  • 2 Cory S. Adams JM. Nat. Rev. Cancer  2002,  2:  647 
    CrossrefPubMedGoogle Scholar
  • 3 Minn AJ. Swain RE. Ma A. Thompson CB. Adv. Immunol.  1998,  70:  245 
    PubMedGoogle Scholar
  • 4 Van D MF. Huang DC. Cell Res.  2006,  16:  203 
    CrossrefPubMedGoogle Scholar
  • 5 Thompson CB. Science  1995,  267:  1456 
    CrossrefPubMedGoogle Scholar
  • 6 Reed JC. Adv. Pharmacol.  1997,  41:  501 
    PubMedGoogle Scholar
  • 7 Danial NN. Korsmeyer SJ. Cell  2004,  116:  205 
    CrossrefPubMedGoogle Scholar
  • 8 Nicholson DW. Nature  2000,  407:  810 
    CrossrefPubMedGoogle Scholar
  • 9 Green DR. Evan GI. Cancer Cell  2002,  1:  19 
    CrossrefPubMedGoogle Scholar
  • 10 Amundson SA. Myers TG. Scudiero D. Kitada S. Reed JC. Fornace AJ. Cancer Res.  2000,  60:  6101 
    PubMedGoogle Scholar
  • 11 Danial NN. Clin. Cancer Res.  2007,  13:  7254 
    CrossrefPubMedGoogle Scholar
  • 12 Adams JM. Cory S. Oncogene  2007,  26:  1324 
    CrossrefPubMedGoogle Scholar
  • For reviews, see:
  • 13a Beauparlant P. Shore GC. Cell Eng.  2004,  4:  223 
    Google Scholar
  • 13b Hangary S. Johnson DE. Leukemia  2003,  17:  1470 
    Google Scholar
  • 13c Huang ZW. Curr. Opin. Drug Discovery Dev.  2000,  3:  565 
    Google Scholar
  • 13d Wang S. Yang D. Lippman ME. Semin. Oncol.  2003,  30:  133 
    Google Scholar
  • 13e Manion MK. Fry J. Schwartz PS. Hockenbery DM. Curr. Opin. Investig. Drugs  2006,  7:  1077 
    Google Scholar
  • 13f Reed JC. Zhai D. Hyer M. Welsh K. Drug Discovery Res.  2007,  408 
    Google Scholar
  • 14 Degterev A. Lugovskoy A. Cardone M. Mulley B. Wagner G. Mitchison T. Yuan J. Nat. Cell Biol.  2001,  3:  173 
    CrossrefPubMedGoogle Scholar
  • 15 Wang JL. Liu D. Zhang ZJ. Shan S. Han X. Srinivasula SM. Croce CM. Alnemri ES. Huang Z. Proc. Natl. Acad. Sci. U.S.A.  2000,  97:  7124 
    CrossrefPubMedGoogle Scholar
  • 16 Tzung SP. Kim KM. Basanez G. Giedt CD. Simon J. Zimmerberg J. Zhang KY. Hockenbery DM. Nat. Cell Biol.  2001,  3:  183 
    CrossrefPubMedGoogle Scholar
  • 17 Kitada S. Leone M. Sareth S. Zhai D. Reed JC. Pellecchia M. J. Med. Chem.  2003,  46:  4259 
    CrossrefPubMedGoogle Scholar
  • 18 Oltersdorf T. Elmore SW. Shoemaker AR. Armstrong RC. Augeri DJ. Belli BA. Bruncko M. Deckwerth TL. Dinges J. Hajduk PJ. Joseph MK. Kitada S. Korsmeyer SJ. Kunzer AR. Letai A. Li C. Mitten MJ. Nettesheim DG. Ng S. Nimmer PM. O’Connor JM. Oleksijew A. Petros AM. Reed JC. Shen W. Tahir SK. Thompson CB. Tomaselli KJ. Wang B. Wendt MD. Zhang H. Fesik SW. Rosenberg SH. Nature  2005,  435:  677 
    CrossrefPubMedGoogle Scholar
  • 19 Tang G. Ding K. Nikolovska-Coleska Z. Yang C.-Y. Qiu S. Shangary S. Wang R. Guo J. Gao W. Meagher J. Stuckey J. Krajewski K. Jiang S. Roller PP. Wang S. J. Med. Chem.  2007,  50:  3163 
    CrossrefPubMedGoogle Scholar
  • 20 Xing C. Saleh M. Pitot H. Hartung J. Holmlund J. AlbertLoBuglio A. Forero AP. The 2005 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery Biology and Clinical Applications, Nov 14-18, 2005, Philadelphia, Pennsylvania   American Association for Cancer Research; Philadelphia, PA: 2005.  Abstract C89.
    Google Scholar
  • 21 Zhang Z. Jin L. Qian X. Wei M. Wang Y. Wang J. Yang Y. Xu Q. Xu Y. Liu F. ChemBioChem  2007,  8:  113 
    CrossrefPubMedGoogle Scholar
  • 22 Petros AM. Dinges J. Augeri DJ. Baumeister SA. Betebenner DA. Bures MG. Elmore SW. Hajduk PJ. Joseph MK. Landis SK. Nettesheim DG. Rosenberg SH. Shen W. Thomas S. Wang X. Zanze I. Zhang H. Fesik SW. J. Med. Chem.  2006,  49:  656 
    CrossrefPubMedGoogle Scholar
  • 23 Wendt MD. Wang S. Kunzer A. McClellan WJ. Bruncko M. Oost TK. Joseph MK. Nimmer PM. Ng S.-C. Shoemaker AR. Petros AM. Oleksijew A. Marsh K. Bauch J. Oltersdorf T. Belli BA. Martineau D. Fesik SW. Rosenberg SH. Elmore SW. J. Med. Chem.  2006,  49:  1165 
    CrossrefPubMedGoogle Scholar
  • 24 Bruncko M. Oost TK. Belli BA. Ding H. Joseph MK. Kunzer A. Martineau D. McClellan WJ. Mitten M. Ng S.-C. Nimmer PM. Oltersdorf T. Park C.-M. Petros AM. Shoemaker AR. Song X. Wang X. Wendt MD. Zhang H. Fesik SW. Rosenberg SH. Elmore SW. J. Med. Chem.  2007,  50:  641 
    CrossrefPubMedGoogle Scholar
  • 25 Park CM. Oie T. Petros AM. Zhang H. Nimmer PM. Henry RF. Elmore SW. J. Am. Chem. Soc.  2006,  128:  16206 
    CrossrefPubMedGoogle Scholar
  • 27 Lock R. Carol H. Houghton PJ. Morton CL. Kolb EA. Gorlick R. Reynolds CP. Maris JM. Keir ST. Wu J. Smith MA. Pediatr. Blood Cancer  2008,  50:  1181 
    CrossrefPubMedGoogle Scholar
  • 28 Bruncko M, Ding H, Elmore SW, Kunzer AR, Lynch CL, McClellan WJ, Park CM, Song X, and Wang X. inventors; US  27135A1.  ; Chem. Abstr. 2007, 146, 229049
  • 29 Steven W, Bruncko M, and Park CM. inventors; US  272744.  ; Chem. Abstr. 2005, 144, 36377
  • 30 Dai K. Minoru I. Mikio Y. Shoichi M. Mitsugu H. Kiyoaki K. Keiichi A. Bioorg. Med. Chem.  2006,  14:  2089 
    CrossrefPubMedGoogle Scholar
  • 31 Ying C. Chun C. J. Fluorine Chem.  2005,  126:  937 
    CrossrefGoogle Scholar
  • 32 Bandgar BP. Bettigeri SV. Phopase J. Org. Lett.  2004,  6:  2105 
    CrossrefPubMedGoogle Scholar
  • 33 Beaumont AJ. Clark JH. J. Fluorine Chem.  1991,  52:  295 
    CrossrefGoogle Scholar
  • 34 Popkova VY, and Marhold A. inventors; EP  109892.  ; Chem. Abstr. 1999, 132, 3248
26

Park C. M.; Abstracts, 41st Western Regional Meeting of the American Chemical Society; San Diego, 2007.